全球獸醫骨科市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1408979

全球獸醫骨科市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Veterinary Orthopedic Medicine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 222 Pages | 商品交期: 最快1-2個工作天內

價格

全球獸用骨科藥物市場需求預計將從 2022 年的 38.8 億美元增至 2030 年的近 77.9 億美元,2023-2030 年研究期間CAGR為 9.11%。

獸醫骨科醫學是指專注於動物肌肉骨骼疾病和損傷的診斷、治療和預防的專業獸醫學。獸醫學的這一分支解決與各種動物物種的骨骼、關節、韌帶、肌腱和肌肉相關的問題。

市場動態

獸醫骨科藥品市場正在幾個關鍵因素的推動下經歷成長。隨著寵物主人尋求肌肉骨骼疾病的先進治療方法,人們對伴侶動物福祉的認知和關注不斷增加,導致對專業獸醫骨科護理的需求不斷成長。由於動物族群老化和活動增加等因素,動物骨科問題(包括骨關節炎和十字韌帶損傷)的盛行率正在上升。獸醫醫療技術和外科技術的進步發揮關鍵作用,骨科植入物和微創手術的創新提高了治療效果。獸醫界內部以及與研究機構的合作有助於知識交流和新治療方式的發展。不斷成長的寵物保險行業進一步影響市場,促進寵物主人獲得先進的骨科治療。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具還對全球獸醫骨科醫學市場的每個細分市場進行了包容性評估。獸醫骨科醫學行業的成長和趨勢為本研究提供了整體方法。

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲獸醫骨科醫學市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。獸醫骨科醫學市場的主要參與者包括Zoetis, Inc.、勃林格殷格翰、Elanco Animal Health、American Regent, Inc.、默克動物保健(Merck & Co. Inc.)、Vetoquinol SA、Ceva Sante Animale、Virbac 、Biogenesis Bago 、Ardent Animal Health, LLC、Bioiberica SAU、PetVivo Holdings, Inc. (Spryng)、Contipro AS、VetStem, Inc.、Enso Discovery、Contura Vet US、T-Cyte Thepeutics。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:獸醫骨科醫學 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按動物分類的市場吸引力分析
    • 市場吸引力分析:依應用分類
    • 按給藥途徑進行的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球獸醫骨科藥物市場分析:依產品

  • 按產品概述
  • 歷史和預測數據
  • 按產品分析
  • 生物製劑(幹細胞、富血小板血漿 (PRP)、單株抗體)
  • 黏稠補充劑
  • 藥品(類固醇、NSAIDS、其他)

第 6 章:全球獸用骨科藥物市場分析:依動物分類

  • 按動物分類概述
  • 歷史和預測數據
  • 動物分析
  • 犬類
  • 貓科動物
  • 馬科
  • 其他

第 7 章:全球獸醫骨科藥物市場分析:按應用分類

  • 概述:按應用
  • 歷史和預測數據
  • 分析:按應用
  • 骨關節炎
  • 退化性關節疾病
  • 關節發炎/疼痛
  • 其他

第 8 章:全球獸醫骨科藥物市場分析:依給藥途徑

  • 依給藥途徑概述
  • 歷史和預測數據
  • 依給藥途徑分析
  • 口服
  • 腸胃外(肌肉內、關節內、其他)
  • 專題

第 9 章:全球獸用骨科藥物市場分析:依最終用途分類

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 獸醫院
  • 獸醫診所
  • 其他

第 10 章:全球獸醫骨科醫學市場分析:依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 11 章:獸醫骨科藥品公司的競爭格局

  • 獸用骨科藥品市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 12 章:公司簡介

  • 公司股份分析
  • 市場集中度
  • Zoetis Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Boehringer Ingelheim
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Elanco Animal Health
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • American Regent Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merck Animal Health (Merck & Co. Inc)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Vetoquinol SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Ceva Sante Animale
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Virbac
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Biogenesis Bago
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Ardent Animal Health LLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bioiberica SAU
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • PetVivo Holdings Inc. (Spryng)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Contipro AS
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • VetStem Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Enso Discoveries
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Contura Vet US
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • T-Cyte Therepeutics
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中,財務詳細資訊和近期發展視情況而定,或者如果是私人公司,則可能不包括在內

Product Code: VMR112113276

The global demand for Veterinary Orthopedic Medicine Market is presumed to reach the market size of nearly USD 7.79 BN by 2030 from USD 3.88 BN in 2022 with a CAGR of 9.11% under the study period 2023 - 2030.

Veterinary orthopedic medicine refers to the specialized veterinary medicine that focuses on the diagnosis, treatment, and prevention of musculoskeletal conditions and injuries in animals. This branch of veterinary medicine addresses issues related to bones, joints, ligaments, tendons, and muscles in various animal species.

MARKET DYNAMICS

The Veterinary orthopedic medicine market is experiencing growth driven by several key factors. Increased awareness and concern for the well-being of companion animals contribute to a rising demand for specialized veterinary orthopedic care as pet owners seek advanced treatments for musculoskeletal conditions. The prevalence of orthopedic issues in animals, including osteoarthritis and cruciate ligament injuries, is on the rise, fueled by factors like aging animal populations and increased engagement in activities. Advancements in veterinary medical technology and surgical techniques play a pivotal role, with innovations in orthopedic implants and minimally invasive procedures enhancing treatment outcomes. Collaborations within the veterinary community and with research institutions contribute to knowledge exchange and the development of new treatment modalities. The growing pet insurance industry further impacts the market, facilitating access to advanced orthopedic treatments for pet owners.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of veterinary orthopedic medicine. The growth and trends of veterinary orthopedic medicine industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the veterinary orthopedic medicine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Biologics (Stem Cells, Platelet-Rich Plasma (Prp), Monoclonal Antibody)
  • Viscosupplements
  • Pharmaceuticals (Steroids, Nsaids, Others)

By Animal

  • Canine
  • Feline
  • Equine
  • Cattle
  • Swine
  • Others

By Application

  • Osteoarthritis
  • Degenerative Joint Disease
  • Joint Inflammation/Pain
  • Other

By Route Of Administration

  • Oral
  • Parenteral (Intra-Muscular, Intra-Articular, Others)
  • Topical

By End-Use

  • Veterinary Hospitals
  • Veterinary Clinics
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Veterinary Orthopedic Medicine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Veterinary Orthopedic Medicine market include Zoetis, Inc., Boehringer Ingelheim, Elanco Animal Health, American Regent, Inc., Merck Animal Health (Merck & Co. Inc), Vetoquinol S.A., Ceva Sante Animale, Virbac, Biogenesis Bago, Ardent Animal Health, LLC, Bioiberica S.A.U, PetVivo Holdings, Inc. (Spryng), Contipro A.S., VetStem, Inc., Enso Discoveries, Contura Vet US, T-Cyte Therepeutics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . VETERINARY ORTHOPEDIC MEDICINE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Animal
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Route of Administration
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Biologics (Stem Cells, Platelet-Rich Plasma (PRP), Monoclonal Antibody) Historic and Forecast Sales by Regions
  • 5.5 Viscosupplements Historic and Forecast Sales by Regions
  • 5.6 Pharmaceuticals (Steroids, NSAIDS, Others) Historic and Forecast Sales by Regions

6 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY ANIMAL

  • 6.1 Overview by Animal
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Animal
  • 6.4 Canine Historic and Forecast Sales by Regions
  • 6.5 Feline Historic and Forecast Sales by Regions
  • 6.6 Equine Historic and Forecast Sales by Regions
  • 6.7 Cattle Historic and Forecast Sales by Regions
  • 6.8 Swine Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Osteoarthritis Historic and Forecast Sales by Regions
  • 7.5 Degenerative Joint Disease Historic and Forecast Sales by Regions
  • 7.6 Joint Inflammation/Pain Historic and Forecast Sales by Regions
  • 7.7 Other Historic and Forecast Sales by Regions

8 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 8.1 Overview by Route of Administration
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Route of Administration
  • 8.4 Oral Historic and Forecast Sales by Regions
  • 8.5 Parenteral (Intra-muscular, Intra-articular, Others) Historic and Forecast Sales by Regions
  • 8.6 Topical Historic and Forecast Sales by Regions

9 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY END-USE

  • 9.1 Overview by End-use
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End-use
  • 9.4 Veterinary Hospitals Historic and Forecast Sales by Regions
  • 9.5 Veterinary Clinics Historic and Forecast Sales by Regions
  • 9.6 Others Historic and Forecast Sales by Regions

10 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. South East Asia Sales Analysis
    • 10.5.10. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE VETERINARY ORTHOPEDIC MEDICINE COMPANIES

  • 11.1. Veterinary Orthopedic Medicine Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF VETERINARY ORTHOPEDIC MEDICINE INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Zoetis Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Boehringer Ingelheim
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Elanco Animal Health
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. American Regent Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Merck Animal Health (Merck & Co. Inc)
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Vetoquinol S.A.
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Ceva Sante Animale
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Virbac
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Biogenesis Bago
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Ardent Animal Health LLC
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Bioiberica S.A.U
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. PetVivo Holdings Inc. (Spryng)
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Contipro A.S.
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. VetStem Inc.
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. Enso Discoveries
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. Contura Vet US
    • 12.18.1. Company Overview
    • 12.18.2. Company Revenue
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. T-Cyte Therepeutics
    • 12.19.1. Company Overview
    • 12.19.2. Company Revenue
    • 12.19.3. Products
    • 12.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Product (USD MN)
  • Biologics (Stem Cells, Platelet-Rich Plasma (PRP), Monoclonal Antibody) Market Sales by Geography (USD MN)
  • Viscosupplements Market Sales by Geography (USD MN)
  • Pharmaceuticals (Steroids, NSAIDS, Others) Market Sales by Geography (USD MN)
  • Analysis Market by Animal (USD MN)
  • Canine Market Sales by Geography (USD MN)
  • Feline Market Sales by Geography (USD MN)
  • Equine Market Sales by Geography (USD MN)
  • Cattle Market Sales by Geography (USD MN)
  • Swine Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Osteoarthritis Market Sales by Geography (USD MN)
  • Degenerative Joint Disease Market Sales by Geography (USD MN)
  • Joint Inflammation/Pain Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Parenteral (Intra-muscular, Intra-articular, Others) Market Sales by Geography (USD MN)
  • Topical Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Veterinary Hospitals Market Sales by Geography (USD MN)
  • Veterinary Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Veterinary Orthopedic Medicine Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Veterinary Orthopedic Medicine Report
  • Market Research Process
  • Market Research Methodology
  • Global Veterinary Orthopedic Medicine Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Animal
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Biologics (Stem Cells, Platelet-Rich Plasma (PRP), Monoclonal Antibody) Market Sales by Geography (USD MN)
  • Viscosupplements Market Sales by Geography (USD MN)
  • Pharmaceuticals (Steroids, NSAIDS, Others) Market Sales by Geography (USD MN)
  • Global Market Analysis by Animal (USD MN)
  • Canine Market Sales by Geography (USD MN)
  • Feline Market Sales by Geography (USD MN)
  • Equine Market Sales by Geography (USD MN)
  • Cattle Market Sales by Geography (USD MN)
  • Swine Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Osteoarthritis Market Sales by Geography (USD MN)
  • Degenerative Joint Disease Market Sales by Geography (USD MN)
  • Joint Inflammation/Pain Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Parenteral (Intra-muscular, Intra-articular, Others) Market Sales by Geography (USD MN)
  • Topical Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Veterinary Hospitals Market Sales by Geography (USD MN)
  • Veterinary Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.